|
Guten morgen zusammen, hab gestern Abend eine mail an psd geschrieben um wenigstens nochmals nachzufragen wie aus deren Sicht der Stand der Dinge ist. Hier Die Antwort: Dear Mr XY Thanks for your query. Big Pharma discussions on BioSilicon are still in progress. Big deals take time. There are other potential deals that could happen as well: Licensing of BrachySil in other regions (one deal already done for China). Licensing deals for Medidur both in ophthalmology and cardio applications. Retisert to be licensed for sale in the EU. All these deals could happen this year and all would be very significant to the company. There is also the commencement of BrachySil Phase IIa trials in pancreatic cancer in June and initial results from the Phase IIb trials of BrachySil in liver cancer to be released later this year. AION is traveling well. They too are in a capital raising stage and have identified 15 diagnostic products based on the BioSilicon technology. AION is keeping quiet for competitive reasons for now, but will emerge later this year with big news. A listing on the ASX will likely occur at this stage in 2007. Kind regards Brian Leedman Grüße Jürgen |
|
| aus der Diskussion: | EyePoint Pharmaceuticals (vorher: PSIVIDA) startet durch !! |
| Autor (Datum des Eintrages): | j23mde (15.05.06 05:52:42) |
| Beitrag: | 4,382 von 12,859 (ID:21582565) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |